Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss from continuing operations $ (38,340,063) $ (3,965,798)
Adjustments to reconcile net loss to net cash (used in) provided by operations:    
Depreciation and amortization 609,818 804,074
Stock-based compensation 25,950 739,729
Amortization of debt discount 6,386,305 16,080,270
Modification of warrants 9,464,991
Penalty for non-payment of debentures 5,710,440
Change in fair value of derivative instruments 105,076 (13,688,678)
Loss on sale of receivables to factor 1,361,053
Gain on disposal of equipment under finance leases (549,524)
Bargain purchase gain for hospitals and medical center (250,000) (7,732,302)
(Loss) income from discontinued operations (791,936) 115,787
Changes in operating assets and liabilities:    
Accounts receivable (3,525,152) (5,648,343)
Inventory 82,010 25,066
Prepaid expenses and other current assets (1,485) 113,042
Accounts payable and checks issued in excess of bank balance 4,932,457 3,497,210
Accrued expenses (327,953) 3,728,038
Income tax assets and liabilities (45,000) (12,243)
Net cash used in operating activities of continuing operations (14,603,489) (6,493,672)
Net cash provided by (used in) operating activities of discontinued operations 182,663 (628,154)
Net cash used in operating activities (14,420,826) (7,121,826)
Cash flows from investing activities:    
Purchase of hospitals and medical center (658,537) (668,983)
Proceeds from the sale of equipment under finance leases 433,612
Purchase of property and equipment (50,801) (103,387)
Net cash used in investing activities of continuing operations (709,338) (338,758)
Net cash provided by investing activities of discontinued operations 800,000
Net cash (used in) provided by investing activities (709,338) 461,242
Cash flows from financing activities:    
Proceeds from issuance of related party note payable and advances 16,478,104 3,582,500
Payments on related party note payable and advances (2,310,000) (4,011,000)
Proceeds from issuance of debentures 3,845,000 8,000,000
Payments on notes payable (5,005,794) (256,481)
Proceeds from issuance of note payable 1,500,000
Proceeds from receivables sold to factors 2,650,000
Receivables paid to factors (1,782,614)
Payments on finance lease obligations (143,930) (654,435)
Net cash provided by financing activities of continuing operations 15,230,766 6,660,584
Net cash used in financing activities of discontinued operations
Net cash provided by financing activities 15,230,766 6,660,584
Net increase in cash 100,602
Cash at beginning of period 6,870
Cash at end of period $ 107,472